Ovarian Cancer: A Quest to Extend Remissions
New treatments aim to lengthen remissions and push back recurrences.
Progress Against Cancer
New treatments aim to lengthen remissions and push back recurrences.
Young women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
Adoptive T-cell therapy shows promise in treating metastatic melanoma.
New oral hormonal therapy offers alternative to injections for some women with metastatic disease.
Hematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.
AI has significant implications for medicine, especially for precision cancer care.
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been pursued for decades with little success. Stimulating an immune response against cancer is more complicated...
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have prolonged survival in some patients with metastatic disease and reduced the risk of relapse in...
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More